# A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

> **NCT00598208** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 325 (actual)

## Conditions studied

- Fertilization

## Interventions

- **DRUG:** corifollitropin alfa
- **DRUG:** Follitropin beta injection

## Key facts

- **NCT ID:** NCT00598208
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-19
- **Primary completion:** 2004-03-15
- **Final completion:** 2004-03-15
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598208, "A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00598208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*